Margaret M. FitzPatrick

Director at AN2 Therapeutics · 2 reported transactions in 1 company · latest trade Sep 1, 2026

Their record

Across their whole record, 1 purchase can be measured; 0 did better than the S&P 500 over the next 6 months.

Typical move −2.6%, S&P 500 +13.3% over the same days.

1 more is too recent to measure.


AN2 TherapeuticsANTX	Bought $11.6K · 2,098 shares	Sep 1, 2026	S&P 500 +1.4%thru Oct 29
AN2 TherapeuticsANTX	Bought $10.1K · 8,610 shares	May 28, 2025	S&P 500 +31.4%thru Oct 29

Sep 1, 2026 · ANTX

$11.6K

S&P 500 +1.4%thru Oct 29

May 28, 2025 · ANTX

$10.1K

S&P 500 +31.4%thru Oct 29

2 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.